Bowhead Specialty (NYSE:BOW – Get Free Report) released its quarterly earnings data on Monday. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01, FiscalAI reports. The business had revenue of $163.86 million during the quarter, compared to analyst estimates of $278.69 million. Bowhead Specialty had a net margin of 10.11% and a return on equity of 14.26%.
Bowhead Specialty Trading Up 0.1%
Bowhead Specialty stock traded up $0.04 during midday trading on Wednesday, reaching $33.52. The stock had a trading volume of 176,738 shares, compared to its average volume of 214,821. Bowhead Specialty has a 52-week low of $21.21 and a 52-week high of $35.07. The company has a fifty day moving average of $29.23 and a 200 day moving average of $26.20. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.02 and a beta of -0.11. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 0.32.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on BOW shares. Piper Sandler downgraded shares of Bowhead Specialty from an “overweight” rating to a “hold” rating and set a $34.00 price target on the stock. in a report on Monday. UBS Group set a $28.00 target price on shares of Bowhead Specialty in a report on Thursday, May 21st. JPMorgan Chase & Co. lifted their target price on shares of Bowhead Specialty from $30.00 to $33.00 and gave the company a “neutral” rating in a research note on Monday, July 20th. Citizens Jmp reduced their price objective on shares of Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research report on Monday, April 13th. Finally, Deutsche Bank Aktiengesellschaft lowered Bowhead Specialty from a “buy” rating to a “hold” rating and set a $34.00 price target for the company. in a research note on Monday. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $33.00.
Institutional Trading of Bowhead Specialty
Several hedge funds and other institutional investors have recently bought and sold shares of BOW. Polar Capital Holdings Plc boosted its position in shares of Bowhead Specialty by 77.6% in the 4th quarter. Polar Capital Holdings Plc now owns 1,225,000 shares of the company’s stock worth $34,962,000 after purchasing an additional 535,065 shares in the last quarter. Vanguard Group Inc. raised its position in Bowhead Specialty by 36.7% during the third quarter. Vanguard Group Inc. now owns 1,506,887 shares of the company’s stock worth $40,746,000 after acquiring an additional 404,199 shares during the period. Gillson Capital LP acquired a new stake in Bowhead Specialty in the 4th quarter worth about $11,317,000. American Family Investments Inc. raised its holdings in shares of Bowhead Specialty by 6.9% during the second quarter. American Family Investments Inc. now owns 5,023,778 shares of the company’s stock valued at $188,542,000 after acquiring an additional 323,017 shares during the last quarter. Finally, Qube Research & Technologies Ltd lifted its position in shares of Bowhead Specialty by 286.5% in the third quarter. Qube Research & Technologies Ltd now owns 326,228 shares of the company’s stock valued at $8,821,000 after acquiring an additional 241,829 shares in the last quarter.
Bowhead Specialty Company Profile
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Read More
- Five stocks we like better than Bowhead Specialty
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
- CoreWeave Powers Up: The Asia Infrastructure Grab
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
